Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

NCT06341621 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1900

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 3-year abemaciclib without chemo
DRUG: treatment of physician's choice

Sponsor

Fudan University